Efficacy News and Research

RSS
A reliable assessment of COVID-19 vaccine protection duration

A reliable assessment of COVID-19 vaccine protection duration

How much do mutations reduce vaccine effectiveness in the Omicron variant?

How much do mutations reduce vaccine effectiveness in the Omicron variant?

SARS-CoV-2 infection and immunity in pregnancy and fetal development

SARS-CoV-2 infection and immunity in pregnancy and fetal development

Factors associated with SARS-CoV-2 breakthrough infection in fully vaccinated individuals

Factors associated with SARS-CoV-2 breakthrough infection in fully vaccinated individuals

Clinical-grade soluble human ACE2 shown to inhibit SARS-CoV-2 Omicron variant

Clinical-grade soluble human ACE2 shown to inhibit SARS-CoV-2 Omicron variant

Booster doses of mRNA vaccines improve humoral immunogenicity in patients with inflammatory bowel disease

Booster doses of mRNA vaccines improve humoral immunogenicity in patients with inflammatory bowel disease

Researchers suggest hybrid convalescent plasma therapy neutralizes the omicron variant

Researchers suggest hybrid convalescent plasma therapy neutralizes the omicron variant

3-dose vaccines deemed ultrapotent against diverse and highly transmissible SARS-CoV-2 Omicron and other variants

3-dose vaccines deemed ultrapotent against diverse and highly transmissible SARS-CoV-2 Omicron and other variants

Exploring immunogenicity and safety after a homologous booster dose of SARS-CoV-2 recombinant spike protein vaccine

Exploring immunogenicity and safety after a homologous booster dose of SARS-CoV-2 recombinant spike protein vaccine

Booster dose of mRNA vaccines found crucial in protecting against SARS-CoV-2 Omicron variants

Booster dose of mRNA vaccines found crucial in protecting against SARS-CoV-2 Omicron variants

Combination of rifampicin and resveratrol helps stop dementia, finds study

Combination of rifampicin and resveratrol helps stop dementia, finds study

Study demonstrates increased effectiveness of third BNT162b2 dose against SARS-CoV-2 infection and hospitalization

Study demonstrates increased effectiveness of third BNT162b2 dose against SARS-CoV-2 infection and hospitalization

Third BNT162b2 dose effectively neutralizes SARS-CoV-2 Omicron pseudovirus

Third BNT162b2 dose effectively neutralizes SARS-CoV-2 Omicron pseudovirus

Double-dose mRNA COVID vaccines effective among dialysis patients

Double-dose mRNA COVID vaccines effective among dialysis patients

Omicron variant of SARS-CoV-2 manifests striking antibody evasion

Omicron variant of SARS-CoV-2 manifests striking antibody evasion

Schools account for a small, but important part of young person's mental health

Schools account for a small, but important part of young person's mental health

Ad5-nCoV vaccine safe and effective against symptomatic, severe COVID-19, trials shows

Ad5-nCoV vaccine safe and effective against symptomatic, severe COVID-19, trials shows

Cryo-EM of Omicron variant reveals antibody evasion by spike-ACE2 complex

Cryo-EM of Omicron variant reveals antibody evasion by spike-ACE2 complex

Exploring immunity and severe disease caused by the SARS-CoV-2 Omicron variant

Exploring immunity and severe disease caused by the SARS-CoV-2 Omicron variant

Protein-based nanoparticle vaccines for protection against SARS-CoV-2

Protein-based nanoparticle vaccines for protection against SARS-CoV-2

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.